Close Menu

Emory Genetics Laboratory

Name: Madhuri Hegde
Title: Executive director, Emory Genetics Laboratory

Emory Genetics Laboratory has named five new directors.
Zunyan Dai has been appointed director of EGL's Cytogenetics Laboratory. He joins EGL from Quest Diagnostics

Emory Genetics Laboratory is now offering Verinata's noninvasive prenatal test, Verifi, to physicians, plans to soon launch a number of cancer panels, and is beginning to expand internationally — inking molecular diagnostic partnerships with Mexico's Genomi-K and AITbiotech in Si

Good Start Genetics has appointed Mark Adams to Chief Information Officer.

Despite an increasing number of clinical laboratories now offering diagnostic exome sequencing, commercial exome kits still have a number of holes in them and miss important regions even in medically relevant genes.

NEW YORK (GenomeWeb News) – RainDance Technologies said today that it has launched a new service program to support its customers who are developing sequencing-based genetic testing panels.

Emory Genetics Laboratory, which has been offering next-generation sequencing-based panels since 2010 on Life Technologies' SOLiD, has now converted all of its panel tests to the Illumina MiSeq system, while running an exome test on the HiSeq 2000, executive director Madhuri Hegd

A team led by clinical researchers from the Emory University School of Medicine has published a paper validating the use of RainDance Technologies' multiplexed PCR-based target enrichment technology upstream of a next-generation sequencing panel for comprehensive mutational analy

Bioneer, the US subsidiary of South Korea's Bioneer Corporation, said recently that it has signed a contract to provide PCR kits to Emory Genetics Laboratory, an Emory University-affiliated provider of clinical and laboratory genetic services.

Pages

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.